Medical Devices - Electrophysiology / Cardiac Ablation Systems
Strategic Profile
The PURE EP Platform is an FDA-cleared, non-invasive Class II device engineered to overcome the limitations of traditional electrophysiology tools by providing significantly enhanced signal detection capabilities. The company has a research agreement with Mayo Foundation with the right to sublicense for patent applications in signal processing, physiologic recording, electrophysiology recording, electrophysiology software, and autonomics.
Cyborg Score Rationale
While 2024 revenue reached $40,000 with 122% growth, losses were $10.51 million. The company underwent a major transition, changing its name to Streamex Corp. in September 2025 to focus on tokenization and commodities markets, representing significant strategic pivot away from core medical device business.
Top Insights
Recent pivot: Company changed focus to RWA tokenization and commodities markets (September 2025), moving away from core EP platform commercialization
FDA-cleared PURE EP technology addresses critical gap in cardiac arrhythmia treatment with signal processing advantages over traditional methods
Mayo Foundation collaboration provides clinical validation and sublicensing rights across multiple electrophysiology and signal processing domains
Early revenue stage with minimal commercialization ($40k in 2024) despite having FDA-cleared product suggests either market access challenges or recent strategic refocus
Named Competitors
CARTO Mapping System — 3D cardiac mapping and navigation system for EP procedures
EnSite Precision Mapping — Multi-channel mapping technology for complex arrhythmias
Rhythmia Mapping System — High-resolution mapping for atrial fibrillation ablation
Recent Developments
(May 2025) Acquired Streamex Exchange Corporation, later rebranding parent company
(September 2025) Changed company name from BioSig Technologies to Streamex Corp., pivoting to tokenization and commodities focus
(March 2025) Announced PURE EP advancement for intracardiac electrogram recording with enhanced precision
Open the full interactive BioSig Technologies, Inc. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.